AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
Log in

OTCMKTS:DCTHDelcath Systems Stock Price, Forecast & News

$7.78
+0.23 (+3.05 %)
(As of 06/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$7.61
Now: $7.78
$7.93
50-Day Range
$7.31
MA: $9.70
$13.00
52-Week Range
$5.15
Now: $7.78
$101.50
Volume40,500 shs
Average Volume34,221 shs
Market Capitalization$21.47 million
P/E RatioN/A
Dividend YieldN/A
Beta0.45
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers. The company is developing melphalan hydrochloride for Injection for use with the Delcath hepatic delivery system to administer high-dose chemotherapy to the liver. It offers melphalan hydrochloride under the Delcath Hepatic CHEMOSAT Delivery System for Melphalan name in Europe. The company was founded in 1988 and is headquartered in New York, New York.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.20 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:DCTH
CUSIPN/A
Phone212-489-2100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.58 million
Book Value($94.88) per share

Profitability

Net Income$-8,880,000.00
Net Margins-561.96%

Miscellaneous

Employees46
Market Cap$21.47 million
Next Earnings Date7/15/2020 (Estimated)
OptionableNot Optionable

Receive DCTH News and Ratings via Email

Sign-up to receive the latest news and ratings for DCTH and its competitors with MarketBeat's FREE daily newsletter.

Delcath Systems (OTCMKTS:DCTH) Frequently Asked Questions

How has Delcath Systems' stock been impacted by COVID-19 (Coronavirus)?

Delcath Systems' stock was trading at $9.20 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, DCTH shares have decreased by 15.4% and is now trading at $7.78. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Delcath Systems?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Delcath Systems in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Delcath Systems.

When is Delcath Systems' next earnings date?

Delcath Systems is scheduled to release its next quarterly earnings announcement on Wednesday, July 15th 2020. View our earnings forecast for Delcath Systems.

How were Delcath Systems' earnings last quarter?

Delcath Systems, Inc. (OTCMKTS:DCTH) issued its earnings results on Thursday, May, 14th. The company reported ($108.07) earnings per share for the quarter. The business earned $0.29 million during the quarter. View Delcath Systems' earnings history.

When did Delcath Systems' stock split? How did Delcath Systems' stock split work?

Shares of Delcath Systems reverse split on Tuesday, October 22nd 2019. The 1-100 reverse split was announced on Friday, October 18th 2019. The number of shares owned by shareholders was adjusted after the market closes on Monday, October 21st 2019. An investor that had 100 shares of Delcath Systems stock prior to the reverse split would have 1 shares after the split.

What price target have analysts set for DCTH?

1 brokers have issued 12-month target prices for Delcath Systems' shares. Their forecasts range from $19.00 to $19.00. On average, they expect Delcath Systems' stock price to reach $19.00 in the next year. This suggests a possible upside of 144.2% from the stock's current price. View analysts' price targets for Delcath Systems.

Has Delcath Systems been receiving favorable news coverage?

Media stories about DCTH stock have trended somewhat positive recently, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Delcath Systems earned a media sentiment score of 1.8 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the next several days. View the latest news aboutDelcath Systems.

Who are some of Delcath Systems' key competitors?

What other stocks do shareholders of Delcath Systems own?

Who are Delcath Systems' key executives?

Delcath Systems' management team includes the following people:
  • Dr. Jennifer K. Simpson, Pres, CEO & Director (Age 51)
  • Ms. Barbra C. Keck M.B.A., MBA, CFO & Sec. (Age 41)
  • Mr. John Purpura, Exec. VP & Global Head of Operations (Age 58)
  • Mr. Thomas Johnson, Sr. Director of Corp. Communications
  • Mr. Robin Wagge, Sr. VP of Rubenstein Associates

What is Delcath Systems' stock symbol?

Delcath Systems trades on the OTCMKTS under the ticker symbol "DCTH."

How do I buy shares of Delcath Systems?

Shares of DCTH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Delcath Systems' stock price today?

One share of DCTH stock can currently be purchased for approximately $7.78.

How big of a company is Delcath Systems?

Delcath Systems has a market capitalization of $21.47 million and generates $1.58 million in revenue each year. Delcath Systems employs 46 workers across the globe.

What is Delcath Systems' official website?

The official website for Delcath Systems is www.delcath.com.

How can I contact Delcath Systems?

Delcath Systems' mailing address is 1633 BROADWAY SUITE 22C, NEW YORK NY, 10019. The company can be reached via phone at 212-489-2100 or via email at [email protected]

This page was last updated on 6/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.